What are the most common drug-induced liver injuries?
27 May 2025
Introduction to Drug-Induced Liver InjuriesThehe liver is an essential organ responsible for processing nutrients, detoxifying chemicals, and metabolizing drugs. Unfortunately, it is also vulnerable to injury from various medications. Drug-induced liver injury (DILI) is a leading cause of liver failure, presenting a significant challenge to healthcare providers. Understanding the common drugs that lead to liver damage can aid in the prevention and timely management of DILI.
Acetaminophen is widely used for its analgesic and antipyretic properties, making it a staple in households worldwide. However, it is one of the most common causes of DILI, particularly when consumed in excessive amounts. Overdose can lead to acute liver failure, necessitating prompt medical intervention. The risk amplifies when acetaminophen is mixed with alcohol or other liver-stressing substances.
2. Antibiotics
Antibiotics are another group of medications frequently associated with liver injury. Drugs such as amoxicillin-clavulanate, isoniazid, and erythromycin have been linked to liver damage. Isoniazid, often used in treating tuberculosis, is notorious for causing liver toxicity, especially in individuals with preexisting liver conditions or those consuming alcohol regularly.
3. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
NSAIDs, including ibuprofen, naproxen, and diclofenac, are commonly used to alleviate pain and inflammation. While generally safe when used appropriately, excessive or prolonged use can lead to liver damage. Individuals with liver conditions should exercise caution and consult healthcare providers before using NSAIDs.
4. Antiepileptic Drugs
Antiepileptic medications, such as valproic acid and carbamazepine, have been associated with liver injury. Valproic acid, in particular, is known for causing hyperammonemia and altered liver function, necessitating regular monitoring of liver enzymes in patients.
5. Statins
Statins, prescribed to lower cholesterol levels, have been implicated in liver injury cases, although serious hepatotoxicity is rare. Routine monitoring of liver function tests is recommended when initiating statin therapy, especially in patients with preexisting liver disorders.
Risk Factors for Drug-Induced Liver Injuries
Various factors increase the susceptibility to DILI, including age, genetic predispositions, preexisting liver conditions, and concurrent use of multiple medications. Alcohol consumption further exacerbates the risk, stressing the importance of disclosing lifestyle habits to healthcare providers. Understanding these risk factors can help in tailoring medication regimens to minimize liver damage.
Diagnosis and Management
Diagnosing DILI involves a thorough review of the patient's medication history, clinical symptoms, and laboratory findings. Symptoms may include jaundice, fatigue, nausea, and abdominal pain. Imaging studies and liver biopsies are sometimes necessary to rule out other causes of liver dysfunction.
Management of DILI focuses on discontinuing the offending medication and providing supportive care. In severe cases, liver transplantation may be necessary. Preventive measures, such as patient education and regular monitoring, are crucial in reducing the incidence of drug-induced liver injuries.
Conclusion
Drug-induced liver injury is a significant concern in healthcare, with certain medications posing higher risks than others. Awareness of the common drugs associated with liver damage and understanding individual risk factors are essential steps in prevention and management. Healthcare providers and patients must work collaboratively to ensure medication efficacy while minimizing the potential for liver harm.
Discover Eureka LS: AI Agents Built for Biopharma Efficiency
Stop wasting time on biopharma busywork. Meet Eureka LS - your AI agent squad for drug discovery.
▶ See how 50+ research teams saved 300+ hours/month
From reducing screening time to simplifying Markush drafting, our AI Agents are ready to deliver immediate value. Explore Eureka LS today and unlock powerful capabilities that help you innovate with confidence.
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.